已发表论文

CMTM 家族与胃肠道肿瘤:一项综合综述

 

Authors Li J, Wang X, Wang X, Liu Y, Zheng N, Xu P, Zhang X, Xue L 

Received 18 January 2022

Accepted for publication 26 March 2022

Published 26 April 2022 Volume 2022:14 Pages 1551—1563

DOI https://doi.org/10.2147/CMAR.S358963

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Seema Singh

Abstract: Gastrointestinal tract cancers are a highly heterogeneous group of malignant diseases, contributing significantly to the burden of death worldwide. Chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTMs) plays important roles in cancer development and progression. Since the first member was cloned, there have been abundant studies on the relationships between the CMTM family and human cancers. It has been reported that the CMTM family has a large potential prognostic value for multiple cancers. Meanwhile, upregulated or downregulated expression of the family members was related to advanced tumor stage, metastasis, and overall survival. Studies have also reported that these proteins play critical roles in antitumor immunity. We performed a systematic review to sum up the latest advances of CMTM family’ roles in gastrointestinal tract cancers, with a primary focus on hepatocellular carcinoma and gastric carcinoma.
Keywords: CMTM family, gastrointestinal tract cancers, MARVEL, hepatocellular carcinoma, gastric carcinoma